Showing 6141-6150 of 10732 results for "".
Understanding the SGR: An Explainer
https://practicaldermatology.com/topics/practice-management/understanding-the-sgr-an-explainer/21194/How did the SGR come to be? If it goes away, what will happen to the misplaced focus on physician payments?New Oral Agent May Shift Psoriasis Treatment Landscape
https://practicaldermatology.com/topics/psoriasis/new-oral-agent-may-shift-psoriasis-treatment-landscape/21258/A notable approval in 2014, apremilast may play an important role in bridging a wide gap in the care of moderate to severe psoriasis.EHR User Series—Part IV
https://practicaldermatology.com/topics/practice-management/ehr-user-seriespart-iv/21494/The final entry in a Q&A series with clinicians about their experience and broader impressions of EHRs in dermatology.Practice Cost Savings, Part IV: Banking
https://practicaldermatology.com/topics/practice-management/practice-cost-savings-part-iv-banking/21520/Evaluation and re-evaluation of banking services and relationships is one of the essential elements of any practice.Practice Cost Savings, Part III: Technology
https://practicaldermatology.com/topics/practice-management/practice-cost-savings-part-iii-technology/21525/From health records to IT, technology presents practices with unique challenges and opportunities for savings.Update on NSAIDs and Skin Cancer Prevention
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-nsaids-and-skin-cancer-prevention/21602/As more data point to protection against melanoma and NMSC, clinical implications are still limited.Cosmetics Challenge: Six Strategies for Scientific Skincare, Part 2 of 2
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge-six-strategies-for-scientific-skincare-part-2-of-2/21934/Clinicians who are familiar with scientifically proven skincare ingredients, knowledgeable about formulations, and adept at combining topical products can help patients achieve or maintain cosmetic rejuvenation goals.High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.Meet the Moys: Father and Daughter Dermatologists Reflect on the Specialty
https://practicaldermatology.com/topics/feature/moy-father-daughter-reflect-on-dermatology-specialty/26578/Meet the Moys: Father and Daughter Dermatologists Reflect on the SpecialtyTest Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.